|
시장보고서
상품코드
1375077
세계의 바이오의약품 동결건조 서비스 유럽 시장 예측 : 지역별 분석 - 서비스 유형별, 최종 사용자별Europe Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Service Type and End User |
||||||
유럽의 바이오의약품 동결건조 서비스 시장은 2023년 7억 9,918만 달러에서 2028년 12억 4,489만 달러로 성장할 것으로 예상되며, 2023년부터 2028년까지 9.3%의 CAGR을 나타낼 것으로 추정됩니다.
유럽 바이오의약품 동결건조 서비스 시장, 위탁생산 및 동결건조 서비스의 급격한 성장으로 견인
바이오의약품 시장은 세계적으로 계속 확대되고 있으며, 제약 산업의 주요 성장 동력이 되고 있습니다. 최근 더 많은 치료용 생물학적 제제가 승인됨에 따라 바이오의약품의 비경구제 제조가 확대되고 있습니다. 생명공학 기업들은 충진 및 마무리 요구를 충족하고 미생물 오염의 위험을 줄이기 위해 위탁생산기관(CMO)에 위탁하고 있습니다. 바이오 제약 회사는 필요에 따라 능력과 역량을 제공하기 위해 위탁 생산 기관(CMO)에 의존하고 있습니다.
내부에 동결 건조 능력과 운영을 설치하려면 특수 장비와 전문 지식이 필요하고 비용과 시간이 많이 소요됩니다. 그러나 아웃소싱은 비용이 저렴하고 제조 공정의 효율성을 높일 수 있습니다. 또한 생명공학 기업은 자원을 다른 분야로 돌릴 수 있습니다. 따라서 의약품 개발 기업 및 바이오 제약 기업은 이러한 업무를 CMO에 아웃소싱하여 전반적인 생산 비용과 수율 비용을 절감합니다. 몇년전까지만 해도 CMO 산업은 틈새 서비스 시장으로 생명공학 기업에 추가 생산 능력과 특정 서비스를 제공했습니다. 생명공학 산업이 대규모 생산에서 틈새 치료 및 표적 치료(맞춤 의료)로 전환함에 따라 유연한 운영 능력, 생산 규모 및 다품종 운영에 대한 수요가 증가하고 있습니다. 이러한 요인으로 인해 CMO에 대한 관심이 높아지고 있습니다. 동결건조 전문 시설과 전용 라인을 제공하는 CMO 중 하나가 주빌리언 홀리스터 스티어(Jubilan Hollister Stier)의 계약 제조 및 서비스입니다. 이 CMO는 1상부터 상업용 무균 주사제까지 무균 충전/마무리 및 일련의 동결건조 서비스를 제공합니다. 주빌란은 서비스 수요 증가에 대응하기 위해 385평방피트 규모의 새로운 동결건조기를 설치했습니다. 이처럼 바이오의약품 CMO의 역량과 가용성 증가는 바이오의약품 동결건조 서비스 시장의 성장을 견인하고 있습니다.
유럽의 바이오의약품 동결건조 서비스 시장 개요
유럽의 바이오의약품 동결건조 서비스 시장은 독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽으로 구분됩니다. 이 지역 시장은 예측 기간 동안 주목할 만한 CAGR을 기록할 것으로 예상됩니다. 독일, 영국, 프랑스와 같은 국가들은 유럽 바이오의약품 시장용 동결건조 서비스 공급 측면을 주도하고 있습니다. 이들 국가에는 사업 확장에 주력하고 있는 다양한 개발 및 제조 수탁 기관(CDMO)도 존재합니다. 이탈리아와 스페인은 벤처캐피털의 성장과 기업들의 무기적인 전략 개발로 인해 바이오의약품 동결건조 서비스 시장의 성장 기회가 확대되고 있습니다.
유럽 바이오의약품 동결건조 서비스 시장 매출 및 2028년까지의 예측(금액)
바이오 의약품을 위한 유럽 동결건조 서비스 시장 세분화
유럽 바이오의약품 동결건조 서비스 시장은 서비스 유형, 최종 사용자, 국가별로 구분됩니다.
서비스 유형별로는 유럽 바이오의약품 동결건조 서비스 시장은 동결건조 사이클 개발, 임상 제조, 상업 제조, 동결건조 분석 서비스로 구분되며, 2023년 유럽 바이오의약품 동결건조 서비스 시장에서 상업 제조 분야가 가장 큰 점유율을 차지할 것으로 예상됩니다.
최종 사용자별로 유럽 바이오의약품 동결건조 서비스 시장은 제약 및 생명공학 기업, 연구기관, 기타로 구분되며, 제약 및 생명공학 기업 부문이 2023년 유럽 바이오의약품 동결건조 서비스 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다.
국가별로는 유럽 바이오의약품 동결건조 서비스 시장은 독일, 영국, 프랑스, 스페인, 이탈리아, 기타 유럽으로 구분되며, 2023년 유럽 바이오의약품 동결건조 서비스 시장은 독일이 주도하고 있습니다.
Berkshire Sterile Manufacturing, Biofortuna, Curia Global Inc, Emergent BioSolutions Inc, Jubilant HollisterStier LLC, PCI Pharma Services, SYNERLAB GROUP이 유럽 바이오의약품 동결건조 서비스 시장에서 사업을 전개하고 있는 주요 기업입니다.
목차
제1장 서론
제2장 유럽의 바이오의약품 동결건조 서비스 시장 - 요점
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 유럽의 바이오의약품 동결건조 서비스 시장 - 시장 구도
- 유럽의 PEST 분석
- 전문가의 견해
제5장 유럽의 바이오의약품 동결건조 서비스 시장 - 주요 시장 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 향후 동향
- 성장 촉진요인과 저해요인의 영향 분석
제6장 유럽의 바이오의약품 동결건조 서비스 시장 분석
- 유럽의 바이오의약품 동결건조 서비스 시장 매출 예측과 분석
제7장 유럽의 바이오의약품 동결건조 서비스 시장 분석과 2028년까지 예측-서비스 유형별
- 유럽의 바이오의약품 동결건조 서비스 시장 : 서비스 유형별 2022년·2028년(%)
- 상업용 제조
- 임상 제조
- 동결건조 사이클 개발
- 동결건조 분석 서비스
제8장 유럽의 바이오의약품 동결건조 서비스 시장 분석과 2028년까지 예측 : 최종사용자별
- 유럽의 바이오의약품 동결건조 서비스 시장 : 최종사용자별 2022년·2028년(%)
- 제약 기업 및 바이오테크놀러지 기업
- 연구기관
- 기타
제9장 바이오의약품용 동결건조 서비스 시장 - 2028년까지 매출과 예측-유럽 분석
제10장 유럽의 바이오의약품 동결건조 서비스 시장 - 업계 상황
- 바이오의약품용 유럽 동결건조 서비스 시장 성장 전략
- 무기적 성장 전략
- 유기적 성장 전략
제11장 기업 개요
- Berkshire Sterile Manufacturing
- PCI Pharma Services
- Curia Global Inc
- Emergent BioSolutions Inc
- Jubilant HollisterStier LLC.
- Biofortuna
- SYNERLAB GROUP
제12장 부록
LSH 23.11.14The Europe lyophilization services for biopharmaceuticals market is expected to grow from US$ 799.18 million in 2023 to US$ 1,244.89 million by 2028. It is estimated to register a CAGR of 9.3% from 2023 to 2028.
Rapid Growth in Contract Manufacturing and Lyophilization Services Fuel Europe Lyophilization Services for Biopharmaceuticals Market
The biopharmaceuticals market continues to expand worldwide, which can be the primary growth driver for the pharmaceutical industry. Biopharmaceutical parenteral manufacturing has expanded recently as more therapeutic biologics have been approved. Biotechnology companies outsource from contract manufacturing organizations (CMOs) to meet their fill-and-finish needs and reduce the risk of microbial contamination. Biopharma companies depend on contract manufacturing organizations (CMOs) to provide capacity and capabilities as needed.
Setting up in-house lyophilization capabilities and operations requires specialized equipment and expertise, which is expensive and time-consuming. However, outsourcing is cheaper and increases the efficiency of manufacturing processes. Additionally, it allows biotechnology companies to redirect resources to other areas. Thus, drug developers and biopharmaceutical companies outsource such operations to CMOs to save overall production and yield cost. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to biotechnology companies. As the biotechnology industry shifts from large-scale production to niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is rising. Owing to all these factors, the inclination toward CMOs is growing. One such CMO that provides specialized facilities and dedicated lines for lyophilization operations is Jubilant HollisterStier Contract Manufacturing & Services. The CMO offers sterile fill/finish of Phase I through a commercial sterile injectable and a full suite of lyophilization services. To keep up with the growing demand for its services, Jubilant installed a new 385-square-foot lyophilizer. Thus, the rising capability and availability of biopharma CMOs fuel the lyophilization services for biopharmaceuticals market growth.
Europe Lyophilization Services for Biopharmaceuticals Market Overview
The Europe lyophilization services for biopharmaceuticals market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The market in this region is estimated to register a notable CAGR during the forecast period. Countries such as Germany, the UK, and France lead the supply side of the lyophilization services for the biopharmaceutical market in Europe. These countries also have the presence of various contract development and manufacturing organizations (CDMOs) that are focused on business expansion in these countries. Italy and Spain have wider growth opportunities for the lyophilization services for biopharmaceuticals market owing to the growing venture capital and inorganic strategic developments by companies.
Europe Lyophilization Services for Biopharmaceuticals Market Revenue and Forecast to 2028 (US$ Million)
Europe Lyophilization Services for Biopharmaceuticals Market Segmentation
The Europe lyophilization services for biopharmaceuticals market is segmented into service type, end user, and country.
Based on service type, the Europe lyophilization services for biopharmaceuticals market is segmented into lyophilization cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. The commercial manufacturing segment held the largest share of the Europe lyophilization services for biopharmaceuticals market in 2023.
By end user, the Europe lyophilization services for biopharmaceuticals market is segmented into pharmaceutical & biotechnology companies, research institutes, and others. The pharmaceutical & biotechnology companies segment held the largest share of the Europe lyophilization services for biopharmaceuticals market in 2023.
Based on country, the Europe lyophilization services for biopharmaceuticals market is segmented into Germany, UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe lyophilization services for biopharmaceuticals market in 2023.
Berkshire Sterile Manufacturing, Biofortuna, Curia Global Inc, Emergent BioSolutions Inc, Jubilant HollisterStier LLC., PCI Pharma Services, and SYNERLAB GROUP are the leading companies operating in the Europe lyophilization services for biopharmaceuticals market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe lyophilization services for biopharmaceuticals market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe lyophilization services for biopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Europe Lyophilization Services for Biopharmaceuticals Market - by Service Type
- 1.3.2 Europe Lyophilization Services for Biopharmaceuticals Market - by End User
- 1.3.3 Europe Lyophilization Services for Biopharmaceuticals Market - by Country
2. Europe Lyophilization Services for Biopharmaceuticals Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe Lyophilization Services for Biopharmaceuticals Market - Market Landscape
- 4.1 Overview
- 4.2 Europe PEST Analysis
- 4.3 Expert's Opinion
5. Europe Lyophilization Services for Biopharmaceuticals Market - Key Market Dynamics
- 5.1 Market Driver
- 5.1.1 Rising Demand for Lyophilized Products
- 5.1.2 Rapid Growth in Contract Manufacturing and Lyophilization Services
- 5.2 Market Restraints
- 5.2.1 Demerits Associated with Lyophilization Process
- 5.3 Market Opportunities
- 5.3.1 Launch of Advanced Lyophilization Technology
- 5.4 Future Trends
- 5.4.1 Growing Number of siRNA and Antibody-Based Formulations
- 5.5 Impact Analysis of Drivers and Restraints
6. Lyophilization Services for Biopharmaceuticals Market - Europe Analysis
- 6.1 Europe Lyophilization Services for Biopharmaceuticals Market Revenue Forecast and Analysis
7. Europe Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by Service Type
- 7.1 Overview
- 7.2 Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
- 7.3 Commercial Manufacturing
- 7.3.1 Overview
- 7.3.2 Commercial Manufacturing: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Clinical Manufacturing
- 7.4.1 Overview
- 7.4.2 Clinical Manufacturing: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Lyophilization Cycle Development
- 7.5.1 Overview
- 7.5.2 Lyophilization Cycle Development: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 Freeze Drying Analytical Services
- 7.6.1 Overview
- 7.6.2 Freeze Drying Analytical Services: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by End User
- 8.1 Overview
- 8.2 Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
- 8.3 Pharmaceutical and Biotechnology Companies
- 8.3.1 Overview
- 8.3.2 Pharmaceutical and Biotechnology Companies: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Research Institutes
- 8.4.1 Overview
- 8.4.2 Research Institutes: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9. Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 -Europe Analysis
- 9.1 Overview
- 9.1.1 Europe Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
- 9.1.1.1 Germany: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 Overview
- 9.1.1.1.2 Germany: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.3 Germany: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
- 9.1.1.1.4 Germany: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.2 France: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Overview
- 9.1.1.2.2 France: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.3 France: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
- 9.1.1.2.4 France: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.3 UK: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Overview
- 9.1.1.3.2 UK: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.3 UK: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
- 9.1.1.3.4 UK: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.4 Italy: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.4.1 Overview
- 9.1.1.4.2 Italy: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.4.3 Italy: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
- 9.1.1.4.4 Italy: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.5 Spain: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.5.1 Overview
- 9.1.1.5.2 Spain: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.5.3 Spain: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
- 9.1.1.5.4 Spain: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.6 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.6.1 Overview
- 9.1.1.6.2 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.6.3 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
- 9.1.1.6.4 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.1 Germany: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1 Europe Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
10. Europe Lyophilization Services for Biopharmaceuticals Market - Industry Landscape
- 10.1 Overview
- 10.2 Growth Strategies in the Europe Lyophilization Services for Biopharmaceuticals Market
- 10.3 Inorganic Growth Strategies
- 10.3.1 Overview
- 10.4 Organic Growth Strategies
- 10.4.1 Overview
11. Company Profiles
- 11.1 Berkshire Sterile Manufacturing
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 PCI Pharma Services
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Curia Global Inc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 Emergent BioSolutions Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Jubilant HollisterStier LLC.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Biofortuna
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 SYNERLAB GROUP
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms
